Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Free PMC article
Full text links

Actions

Share

.2023 Mar 13;10(4):003781.
doi: 10.12890/2023_003781. eCollection 2023.

Acute Onset of Bullous Skin Rash and Acute Kidney Injury after Exposure to Radiocontrast: Sweet's Syndrome

Affiliations

Acute Onset of Bullous Skin Rash and Acute Kidney Injury after Exposure to Radiocontrast: Sweet's Syndrome

Mahmoud Abdelnabi et al. Eur J Case Rep Intern Med..

Abstract

Sweet's syndrome or acute febrile neutrophilic dermatosis is characterized by an acute inflammatory skin eruption of oedematous and erythematous papules, plaques or nodules, accompanied by fever, and leucocytosis with possible extracutaneous involvement. Aetiologies include infections, inflammatory bowel disease, pregnancy or malignancy, or the syndrome may be drug-induced by many classes of medications or very rarely, radiocontrast exposure. Herein, the authors report a case of radiocontrast-induced bullous Sweet's syndrome and contrast-induced acute kidney injury in a woman in her 60s with a complex medical history.

Learning points: Patients with Sweet's syndrome (SS) typically present with acute-onset fever, leucocytosis, and erythematous, tender plaques with dense neutrophilic infiltration in the dermis. The condition is classified into three subtypes: classic SS, malignancy-associated SS, and drug-induced SS.Drug-induced SS is characterized by an abrupt onset of a painful erythematous rash, dense neutrophilic dermal infiltrate without vasculitis, a temporal relationship between exposure and onset, and resolution of symptoms after drug discontinuation and/or corticosteroid therapy.Treatment options include systemic corticosteroids as first-line therapy, while colchicine, dapsone, indomethacin, naproxen, clofazimine, ciclosporin, α-interferon, and potassium iodide may be considered as second-line therapies in cases resistant to corticosteroids.

Keywords: Sweet’s syndrome; acute febrile neutrophilic dermatosis; acute kidney injury; drug-induced; oesophageal ulcers; radiocontrast-induced.

© EFIM 2023.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: The Authors declare that there are no competing interests.

Figures

Figure 1
Figure 1
Tender haemorrhagic bullae on both arms, inner thighs, and mouth
Figure 2
Figure 2
Skin biopsy showing diffuse neutrophilic infiltration in the dermis with no evidence of leukocytoclastic vasculitis, consistent with Sweet’s syndrome
Figure 3
Figure 3
Esophagogastroduodenoscopy showing oesophageal ulcers (marked by circles)
Figure 4
Figure 4
Colonoscopy showing rectal ulcers (marked by arrowheads)
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Cohen PR. Sweet’s syndrome–a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:1–28. - PMC - PubMed
    1. Callen JP. Neutrophilic dermatoses. Dermatol Clin. 2002;20:409–419. - PubMed
    1. Heath MS, Ortega-Loayza AG. Insights into the pathogenesis of Sweet’s syndrome. Front Immunol. 2019;10:414. - PMC - PubMed
    1. Sáez M, García-Bustínduy M, Noda A, Dorta S, Escoda M, Fagundo E, et al. Drug-induced Sweet’s syndrome. J Eur Acad Dermatol Venereol. 2004;18:233. - PubMed
    1. Yuchi H, Yamaga J, Ishikawa N, Aoki T, Sakata J, Eto T. Endoscopic appearance of the GI lesions associated with Sweet’s syndrome. Gastrointest Endosc. 2000;52:287–289. - PubMed

Related information

LinkOut - more resources

Full text links
Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp